AZ beefs up myasthenia gravis pedigree with US, EU Klygefa nodsFiercepharma·Nov 16, 2026 at 03:43 PMAZN-0.95%AZN
AstraZeneca Secures Dual Rare Disease and Bladder Cancer Approvals Across US, Europebenzinga_article·Nov 16, 2026 at 12:52 PMAZN-0.95%AZNCF
AstraZeneca secures FDA approval for Imfinzi combo in MIBCPharmaceutical Technology·Nov 16, 2026 at 09:37 AMAZN-0.95%AZN
AstraZeneca: Alexion's Klygefa Gets EU Approval To Treat Adults With Generalised Myasthenia Gravisrttnews·Nov 16, 2026 at 07:45 AMAZN-0.95%AZN
REG - AstraZeneca PLC - Baxfendy recommended for approval in the EULondon Stock Exchange·Nov 16, 2026 at 07:15 AMAZN-0.95%AZN
How Investors Are Reacting To Nestlé (SWX:NESN) Regen Farming PactSimplywall·Nov 17, 2026 at 05:23 PMNSRGF-0.99%
AstraZeneca (AZN) Wins FDA Approval for IMFINZI Bladder Cancer RegimenTradingView·Nov 13, 2026 at 11:39 PMAZN-0.95%AZN
AstraZeneca's Baxfendy wins EU panel backing for hypertension treatmentPUBT·Nov 13, 2026 at 11:47 AMAZN-0.95%AZN
China Adds Record 51 Innovative Drugs to Public Medical Insurance CatalogYicai·Nov 16, 2026 at 11:44 AMAZN-0.95%NVO-2.16%
Is AstraZeneca (LSE:AZN) Still Cheap After Its 83% Five Year Run?Simplywall·Nov 14, 2026 at 01:07 AMAZN-0.95%AZN
Sofinnova Partners backs European life sciences sector with €725M raisePharmaceutical Technology·Nov 16, 2026 at 09:53 AMABVX-1.81%AHKSY-1.40%
Nine Listings Transfer to the NYSE in 2026 Amounting to $500B in Market Cap | ICE Stock NewsStockTitan·Nov 12, 2026 at 09:45 AMAZN-0.95%CRTO-5.26%
AstraZeneca acquires bacterial vaccine biotech, OmniosePharmaceutical Technology·Nov 11, 2026 at 02:58 PMAZN-0.95%AZN